Click for best price
Molecular Diagnostics Systems Market Size, Share 2022
Market Analysis and Insights: Global Molecular Diagnostics Systems Market
The global Molecular Diagnostics Systems market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics Systems market.
Global Molecular Diagnostics Systems Scope and Market Size
Molecular Diagnostics Systems market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Molecular Diagnostics Systems market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
PCR
Hybridization
DNA Sequencing
Segment by Application
Hospitals
Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Abbott Laboratories
Qiagen N.V.
Roche Diagnostics
Hologic, Inc.
Grifols
Siemens Healthcare
Becton, Dickinson and Company
Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
Biom?rieux Sa
Cepheid Inc
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Molecular Diagnostics Systems product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Molecular Diagnostics Systems, with price, sales, revenue, and global market share of Molecular Diagnostics Systems from 2019 to 2022.
Chapter 3, the Molecular Diagnostics Systems competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Molecular Diagnostics Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Molecular Diagnostics Systems market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Diagnostics Systems.
Chapter 13, 14, and 15, to describe Molecular Diagnostics Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Molecular Diagnostics Systems Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Molecular Diagnostics Systems Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
104 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Molecular Diagnostics Systems Product Introduction
1.2 Global Molecular Diagnostics Systems Outlook 2017 VS 2022 VS 2028
1.2.1 Global Molecular Diagnostics Systems Sales in US$ Million for the Year 2017-2028
1.2.2 Global Molecular Diagnostics Systems Sales in Volume for the Year 2017-2028
1.3 United States Molecular Diagnostics Systems Outlook 2017 VS 2022 VS 2028
1.3.1 United States Molecular Diagnostics Systems Sales in US$ Million for the Year 2017-2028
1.3.2 United States Molecular Diagnostics Systems Sales in Volume for the Year 2017-2028
1.4 Molecular Diagnostics Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Molecular Diagnostics Systems in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Molecular Diagnostics Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Molecular Diagnostics Systems Market Dynamics
1.5.1 Molecular Diagnostics Systems Industry Trends
1.5.2 Molecular Diagnostics Systems Market Drivers
1.5.3 Molecular Diagnostics Systems Market Challenges
1.5.4 Molecular Diagnostics Systems Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Molecular Diagnostics Systems Market Segment by Type
2.1.1 PCR
2.1.2 Hybridization
2.1.3 DNA Sequencing
2.2 Global Molecular Diagnostics Systems Market Size by Type
2.2.1 Global Molecular Diagnostics Systems Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Molecular Diagnostics Systems Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Molecular Diagnostics Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Molecular Diagnostics Systems Market Size by Type
2.3.1 United States Molecular Diagnostics Systems Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Molecular Diagnostics Systems Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Molecular Diagnostics Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Molecular Diagnostics Systems Market Segment by Application
3.1.1 Hospitals
3.1.2 Laboratories
3.2 Global Molecular Diagnostics Systems Market Size by Application
3.2.1 Global Molecular Diagnostics Systems Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Molecular Diagnostics Systems Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Molecular Diagnostics Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Molecular Diagnostics Systems Market Size by Application
3.3.1 United States Molecular Diagnostics Systems Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Molecular Diagnostics Systems Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Molecular Diagnostics Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Molecular Diagnostics Systems Competitor Landscape by Company
4.1 Global Molecular Diagnostics Systems Market Size by Company
4.1.1 Top Global Molecular Diagnostics Systems Manufacturers Ranked by Revenue (2021)
4.1.2 Global Molecular Diagnostics Systems Revenue by Manufacturer (2017-2022)
4.1.3 Global Molecular Diagnostics Systems Sales by Manufacturer (2017-2022)
4.1.4 Global Molecular Diagnostics Systems Price by Manufacturer (2017-2022)
4.2 Global Molecular Diagnostics Systems Concentration Ratio (CR)
4.2.1 Molecular Diagnostics Systems Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Molecular Diagnostics Systems in 2021
4.2.3 Global Molecular Diagnostics Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Molecular Diagnostics Systems Manufacturing Base Distribution, Product Type
4.3.1 Global Molecular Diagnostics Systems Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Molecular Diagnostics Systems Product Type
4.3.3 Date of International Manufacturers Enter into Molecular Diagnostics Systems Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Molecular Diagnostics Systems Market Size by Company
4.5.1 Top Molecular Diagnostics Systems Players in United States, Ranked by Revenue (2021)
4.5.2 United States Molecular Diagnostics Systems Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Molecular Diagnostics Systems Sales by Players (2020, 2021 & 2022)
5 Global Molecular Diagnostics Systems Market Size by Region
5.1 Global Molecular Diagnostics Systems Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Molecular Diagnostics Systems Market Size in Volume by Region (2017-2028)
5.2.1 Global Molecular Diagnostics Systems Sales in Volume by Region: 2017-2022
5.2.2 Global Molecular Diagnostics Systems Sales in Volume Forecast by Region (2023-2028)
5.3 Global Molecular Diagnostics Systems Market Size in Value by Region (2017-2028)
5.3.1 Global Molecular Diagnostics Systems Sales in Value by Region: 2017-2022
5.3.2 Global Molecular Diagnostics Systems Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Molecular Diagnostics Systems Market Size YoY Growth 2017-2028
6.1.2 North America Molecular Diagnostics Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Molecular Diagnostics Systems Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Molecular Diagnostics Systems Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Molecular Diagnostics Systems Market Size YoY Growth 2017-2028
6.3.2 Europe Molecular Diagnostics Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Molecular Diagnostics Systems Market Size YoY Growth 2017-2028
6.4.2 Latin America Molecular Diagnostics Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Molecular Diagnostics Systems Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Molecular Diagnostics Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporation Information
7.1.2 Abbott Laboratories Description and Business Overview
7.1.3 Abbott Laboratories Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Abbott Laboratories Molecular Diagnostics Systems Products Offered
7.1.5 Abbott Laboratories Recent Development
7.2 Qiagen N.V.
7.2.1 Qiagen N.V. Corporation Information
7.2.2 Qiagen N.V. Description and Business Overview
7.2.3 Qiagen N.V. Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Qiagen N.V. Molecular Diagnostics Systems Products Offered
7.2.5 Qiagen N.V. Recent Development
7.3 Roche Diagnostics
7.3.1 Roche Diagnostics Corporation Information
7.3.2 Roche Diagnostics Description and Business Overview
7.3.3 Roche Diagnostics Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Roche Diagnostics Molecular Diagnostics Systems Products Offered
7.3.5 Roche Diagnostics Recent Development
7.4 Hologic, Inc.
7.4.1 Hologic, Inc. Corporation Information
7.4.2 Hologic, Inc. Description and Business Overview
7.4.3 Hologic, Inc. Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Hologic, Inc. Molecular Diagnostics Systems Products Offered
7.4.5 Hologic, Inc. Recent Development
7.5 Grifols
7.5.1 Grifols Corporation Information
7.5.2 Grifols Description and Business Overview
7.5.3 Grifols Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Grifols Molecular Diagnostics Systems Products Offered
7.5.5 Grifols Recent Development
7.6 Siemens Healthcare
7.6.1 Siemens Healthcare Corporation Information
7.6.2 Siemens Healthcare Description and Business Overview
7.6.3 Siemens Healthcare Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Siemens Healthcare Molecular Diagnostics Systems Products Offered
7.6.5 Siemens Healthcare Recent Development
7.7 Becton, Dickinson and Company
7.7.1 Becton, Dickinson and Company Corporation Information
7.7.2 Becton, Dickinson and Company Description and Business Overview
7.7.3 Becton, Dickinson and Company Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Becton, Dickinson and Company Molecular Diagnostics Systems Products Offered
7.7.5 Becton, Dickinson and Company Recent Development
7.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
7.8.1 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Corporation Information
7.8.2 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Description and Business Overview
7.8.3 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Products Offered
7.8.5 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Development
7.9 Biom?rieux Sa
7.9.1 Biom?rieux Sa Corporation Information
7.9.2 Biom?rieux Sa Description and Business Overview
7.9.3 Biom?rieux Sa Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Biom?rieux Sa Molecular Diagnostics Systems Products Offered
7.9.5 Biom?rieux Sa Recent Development
7.10 Cepheid Inc
7.10.1 Cepheid Inc Corporation Information
7.10.2 Cepheid Inc Description and Business Overview
7.10.3 Cepheid Inc Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Cepheid Inc Molecular Diagnostics Systems Products Offered
7.10.5 Cepheid Inc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Molecular Diagnostics Systems Industry Chain Analysis
8.2 Molecular Diagnostics Systems Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Molecular Diagnostics Systems Distributors
8.3 Molecular Diagnostics Systems Production Mode & Process
8.4 Molecular Diagnostics Systems Sales and Marketing
8.4.1 Molecular Diagnostics Systems Sales Channels
8.4.2 Molecular Diagnostics Systems Distributors
8.5 Molecular Diagnostics Systems Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Molecular Diagnostics Systems CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Molecular Diagnostics Systems Market Trends
Table 3. Molecular Diagnostics Systems Market Drivers
Table 4. Molecular Diagnostics Systems Market Challenges
Table 5. Molecular Diagnostics Systems Market Restraints
Table 6. Global Molecular Diagnostics Systems Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Molecular Diagnostics Systems Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Molecular Diagnostics Systems Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Molecular Diagnostics Systems Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Molecular Diagnostics Systems Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Molecular Diagnostics Systems Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Molecular Diagnostics Systems Revenue Share by Manufacturer, 2017-2022
Table 13. Global Molecular Diagnostics Systems Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Molecular Diagnostics Systems Sales Share by Manufacturer, 2017-2022
Table 15. Global Molecular Diagnostics Systems Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Molecular Diagnostics Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Molecular Diagnostics Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Systems as of 2021)
Table 18. Top Players of Molecular Diagnostics Systems in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Molecular Diagnostics Systems Product Type
Table 20. Date of International Manufacturers Enter into Molecular Diagnostics Systems Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Molecular Diagnostics Systems Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Molecular Diagnostics Systems Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Molecular Diagnostics Systems Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Molecular Diagnostics Systems Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Molecular Diagnostics Systems Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Molecular Diagnostics Systems Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Molecular Diagnostics Systems Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Molecular Diagnostics Systems Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Molecular Diagnostics Systems Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Molecular Diagnostics Systems Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Molecular Diagnostics Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Molecular Diagnostics Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Molecular Diagnostics Systems Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Molecular Diagnostics Systems Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Molecular Diagnostics Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Molecular Diagnostics Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Molecular Diagnostics Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Molecular Diagnostics Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Molecular Diagnostics Systems Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Molecular Diagnostics Systems Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Abbott Laboratories Corporation Information
Table 43. Abbott Laboratories Description and Business Overview
Table 44. Abbott Laboratories Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Abbott Laboratories Molecular Diagnostics Systems Product
Table 46. Abbott Laboratories Recent Development
Table 47. Qiagen N.V. Corporation Information
Table 48. Qiagen N.V. Description and Business Overview
Table 49. Qiagen N.V. Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Qiagen N.V. Product
Table 51. Qiagen N.V. Recent Development
Table 52. Roche Diagnostics Corporation Information
Table 53. Roche Diagnostics Description and Business Overview
Table 54. Roche Diagnostics Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Roche Diagnostics Product
Table 56. Roche Diagnostics Recent Development
Table 57. Hologic, Inc. Corporation Information
Table 58. Hologic, Inc. Description and Business Overview
Table 59. Hologic, Inc. Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Hologic, Inc. Product
Table 61. Hologic, Inc. Recent Development
Table 62. Grifols Corporation Information
Table 63. Grifols Description and Business Overview
Table 64. Grifols Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Grifols Product
Table 66. Grifols Recent Development
Table 67. Siemens Healthcare Corporation Information
Table 68. Siemens Healthcare Description and Business Overview
Table 69. Siemens Healthcare Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Siemens Healthcare Product
Table 71. Siemens Healthcare Recent Development
Table 72. Becton, Dickinson and Company Corporation Information
Table 73. Becton, Dickinson and Company Description and Business Overview
Table 74. Becton, Dickinson and Company Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Becton, Dickinson and Company Product
Table 76. Becton, Dickinson and Company Recent Development
Table 77. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Corporation Information
Table 78. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Description and Business Overview
Table 79. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Product
Table 81. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Development
Table 82. Biom?rieux Sa Corporation Information
Table 83. Biom?rieux Sa Description and Business Overview
Table 84. Biom?rieux Sa Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Biom?rieux Sa Product
Table 86. Biom?rieux Sa Recent Development
Table 87. Cepheid Inc Corporation Information
Table 88. Cepheid Inc Description and Business Overview
Table 89. Cepheid Inc Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Cepheid Inc Product
Table 91. Cepheid Inc Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Molecular Diagnostics Systems Customers List
Table 95. Molecular Diagnostics Systems Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Molecular Diagnostics Systems Product Picture
Figure 2. Global Molecular Diagnostics Systems Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Molecular Diagnostics Systems Market Size 2017-2028 (US$ Million)
Figure 4. Global Molecular Diagnostics Systems Sales 2017-2028 (K Units)
Figure 5. United States Molecular Diagnostics Systems Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Molecular Diagnostics Systems Market Size 2017-2028 (US$ Million)
Figure 7. United States Molecular Diagnostics Systems Sales 2017-2028 (K Units)
Figure 8. United States Molecular Diagnostics Systems Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Molecular Diagnostics Systems Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Molecular Diagnostics Systems Report Years Considered
Figure 11. Product Picture of PCR
Figure 12. Product Picture of Hybridization
Figure 13. Product Picture of DNA Sequencing
Figure 14. Global Molecular Diagnostics Systems Market Share by Type in 2022 & 2028
Figure 15. Global Molecular Diagnostics Systems Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Molecular Diagnostics Systems Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Molecular Diagnostics Systems Sales by Type (2017-2028) & (K Units)
Figure 18. Global Molecular Diagnostics Systems Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Molecular Diagnostics Systems Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Molecular Diagnostics Systems Market Share by Type in 2022 & 2028
Figure 21. United States Molecular Diagnostics Systems Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Molecular Diagnostics Systems Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Molecular Diagnostics Systems Sales by Type (2017-2028) & (K Units)
Figure 24. United States Molecular Diagnostics Systems Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Molecular Diagnostics Systems Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Hospitals
Figure 27. Product Picture of Laboratories
Figure 28. Global Molecular Diagnostics Systems Market Share by Application in 2022 & 2028
Figure 29. Global Molecular Diagnostics Systems Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Molecular Diagnostics Systems Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Molecular Diagnostics Systems Sales by Application (2017-2028) & (K Units)
Figure 32. Global Molecular Diagnostics Systems Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Molecular Diagnostics Systems Price by Application (2017-2028) & (USD/Unit)
Figure 34. United States Molecular Diagnostics Systems Market Share by Application in 2022 & 2028
Figure 35. United States Molecular Diagnostics Systems Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Molecular Diagnostics Systems Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Molecular Diagnostics Systems Sales by Application (2017-2028) & (K Units)
Figure 38. United States Molecular Diagnostics Systems Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Molecular Diagnostics Systems Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Molecular Diagnostics Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 41. North America Molecular Diagnostics Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Molecular Diagnostics Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. Europe Molecular Diagnostics Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Molecular Diagnostics Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Asia-Pacific Molecular Diagnostics Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. China Taiwan Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Molecular Diagnostics Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 63. Latin America Molecular Diagnostics Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Molecular Diagnostics Systems Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 68. Middle East & Africa Molecular Diagnostics Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. UAE Molecular Diagnostics Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Molecular Diagnostics Systems Value Chain
Figure 73. Molecular Diagnostics Systems Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
